Over the last 12 months, INSMED insiders reported no purchases and 47 sales totaling $138.0M across SEC Form 4 filings. 62% of those filings were made under pre-arranged 10b5-1 trading plans.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Decision | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Brennan David RD | ▼ Sale | Discretionaryopen market | 25,000 | $124 | $3.1M | -38.9% | — |
| Aug 17, 2026 | SHAROKY MELVIN MDD | ▼ Sale | Discretionaryopen market | 5,000 | $127.53 | $638K | -100% | indirect |
| Aug 10, 2026 | Adsett RogerChief Operating Officer · O | ▼ Sale | Discretionaryexercise and sell | 239,850 | $133.27 | $32.0M | -70.8% | — |
| Aug 6, 2026 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 27,173 | $128.61 | $3.5M | -31% | 2 tranches |
| Jul 23, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,700 | $106.06 | $1.1M | -4% | 2 tranches |
| Jul 9, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $117.4 | $1.3M | -4% | 3 tranches |
| Jul 6, 2026 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 12,302 | $109.98 | $1.4M | -16.9% | 2 tranches |
| Jun 25, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 21,398 | $103.32 | $2.2M | -7.6% | 5 tranches |
| Jun 22, 2026 | Smith Michael AlexanderChief Legal Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 1,806 | $95.82 | $173K | -4.6% | — |
| Jun 8, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 6,515 | $94.03 | $613K | -2.5% | — |
| Jun 5, 2026 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 4,424 | $102.9 | $455K | -6.8% | 2 tranches |
| Jun 3, 2026 | Adsett RogerChief Operating Officer · O | ▼ Sale | Non-discretionarytax on vesting | 2,370 | $102.27 | $242K | -2.3% | — |
| Jun 3, 2026 | Bonstein SaraChief Financial Officer · O | ▼ Sale | Non-discretionarytax on vesting | 2,404 | $102.27 | $246K | -3.4% | — |
| Jun 3, 2026 | Smith Michael AlexanderChief Legal Officer · O | ▼ Sale | Non-discretionarytax on vesting | 2,159 | $102.27 | $221K | -5.2% | — |
| Jun 3, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionarytax on vesting | 7,605 | $102.27 | $778K | -2.8% | — |
| May 4, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $137.34 | $1.5M | -3.4% | 6 tranches |
| Apr 16, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $143.97 | $1.5M | -3.4% | 4 tranches |
| Apr 6, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $163.22 | $1.7M | -3.4% | 3 tranches |
| Apr 1, 2026 | Adsett RogerChief Operating Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 88,060 | $164.63 | $14.5M | -45.2% | 3 tranches |
| Mar 30, 2026 | Smith Michael AlexanderChief Legal Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 19,638 | $150.98 | $3.0M | -27.5% | — |
| Mar 19, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $143.52 | $1.5M | -3.4% | 3 tranches |
| Mar 5, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $146.03 | $1.6M | -3.4% | 4 tranches |
| Feb 24, 2026 | Smith Michael AlexanderChief Legal Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 24,774 | $155.77 | $3.9M | -32.3% | 3 tranches |
| Feb 19, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $150.97 | $1.6M | -3.4% | 5 tranches |
| Feb 9, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 13,396 | $147.79 | $2.0M | -4.3% | 3 tranches |
| Feb 5, 2026 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 869 | $152.44 | $132K | -1% | — |
| Feb 3, 2026 | Smith Michael AlexanderChief Legal Officer · O | ▼ Sale | Non-discretionarytax on vesting | 640 | $156.27 | $100K | -1.1% | — |
| Feb 3, 2026 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 8,777 | $154.7 | $1.4M | -9.4% | 6 tranches |
| Feb 3, 2026 | Adsett RogerChief Operating Officer · O | ▼ Sale | Non-discretionarytax on vesting | 791 | $156.17 | $124K | -0.7% | — |
| Feb 3, 2026 | Bonstein SaraChief Financial Officer · O | ▼ Sale | Non-discretionarytax on vesting | 748 | $156.34 | $117K | -0.9% | — |
| Feb 3, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionarytax on vesting | 3,009 | $156.34 | $470K | -1% | — |
| Jan 20, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $158.93 | $1.7M | -3.4% | 5 tranches |
| Jan 12, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 19,215 | $169 | $3.2M | -5.9% | 7 tranches |
| Jan 9, 2026 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 1,887 | $186.19 | $351K | -2.2% | — |
| Jan 8, 2026 | Smith Michael AlexanderChief Legal Officer · O | ▼ Sale | Non-discretionarytax on vesting | 3,158 | $174 | $549K | -5.2% | 3 tranches |
| Jan 8, 2026 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 16,530 | $174.06 | $2.9M | -16% | 7 tranches |
| Jan 8, 2026 | Adsett RogerChief Operating Officer · O | ▼ Sale | Non-discretionarytax on vesting | 4,290 | $174.06 | $747K | -3.8% | 3 tranches |
| Jan 8, 2026 | Bonstein SaraChief Financial Officer · O | ▼ Sale | Non-discretionarytax on vesting | 4,642 | $174.22 | $809K | -5.5% | 3 tranches |
| Jan 8, 2026 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionarytax on vesting | 9,676 | $174.03 | $1.7M | -3% | 3 tranches |
| Jan 5, 2026 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 12,303 | $171.38 | $2.1M | -11.5% | 7 tranches |
| Jan 2, 2026 | Schaeffer Orlov S NicoleChief People Strategy Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 87,290 | $175.2 | $15.3M | -67.6% | 5 tranches |
| Dec 18, 2025 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $166.97 | $1.8M | -3.4% | 10 tranches |
| Dec 5, 2025 | SHAROKY MELVIN MDD | ▼ Sale | Discretionaryopen market | 20,000 | $205.01 | $4.1M | -7.6% | — |
| Dec 4, 2025 | Lewis WilliamChair and CEO · O·D | ▼ Sale | Non-discretionary10b5-1 plan | 10,699 | $205.62 | $2.2M | -3.4% | 4 tranches |
| Dec 1, 2025 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 8,895 | $206.98 | $1.8M | -9.7% | 3 tranches |
| Nov 24, 2025 | ANDERSON ELIZABETH MD | ▼ Sale | Discretionaryopen market | 5,000 | $204.58 | $1.0M | -7.8% | — |
| Nov 17, 2025 | LEE LEOD | ▼ Sale | Discretionaryopen market | 75,000 | $195.9 | $14.7M | -57.8% | 5 tranches |
| Nov 14, 2025 | ANDERSON ELIZABETH MD | ▼ Sale | Discretionaryopen market | 10,000 | $195.87 | $2.0M | -13.6% | — |
| Nov 12, 2025 | Schaeffer Orlov S NicoleChief People Strategy Officer · O | ▼ Sale | Discretionaryexercise and sell | 30,000 | $194 | $5.8M | -45.1% | 4 tranches |
| Nov 11, 2025 | Flammer Martina M.D.Chief Medical Officer · O | ▼ Sale | Non-discretionary10b5-1 plan | 31,226 | $189.68 | $5.9M | -27.3% | 4 tranches |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? INSMED filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $INSM feed.